These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25409416)

  • 21. Syntheses, DNA binding and anticancer profiles of L-glutamic acid ligand and its copper(II) and ruthenium(III) complexes.
    Ali I; Wani WA; Saleem K; Wesselinova D
    Med Chem; 2013 Feb; 9(1):11-21. PubMed ID: 22741786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ruthenium-porphyrin conjugates with cytotoxic and phototoxic antitumor activity.
    Gianferrara T; Bergamo A; Bratsos I; Milani B; Spagnul C; Sava G; Alessio E
    J Med Chem; 2010 Jun; 53(12):4678-90. PubMed ID: 20491441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of some ruthenium chelates on MCa mammary carcinoma and on TLX5 lymphoma in mice.
    Bregant F; Pacor S; Ghosh S; Chattopadhyay SK; Sava G
    Anticancer Res; 1993; 13(4):1011-7. PubMed ID: 8352519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for the preparation of ruthenium complexes with potential anticancer activity.
    Bratsos I; Urankar D; Zangrando E; Genova-Kalou P; Košmrlj J; Alessio E; Turel I
    Dalton Trans; 2011 May; 40(19):5188-99. PubMed ID: 21465046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy.
    Silva Dde O
    Anticancer Agents Med Chem; 2010 May; 10(4):312-23. PubMed ID: 20380636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRCA1-Associated Triple-Negative Breast Cancer and Potential Treatment for Ruthenium-Based Compounds.
    Hongthong K; Ratanaphan A
    Curr Cancer Drug Targets; 2016; 16(7):606-17. PubMed ID: 26845433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
    Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
    PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro cytotoxicity and in vivo zebrafish toxicity evaluation of Ru(ii)/2-mercaptopyrimidine complexes.
    Velozo-Sá VS; Pereira LR; Lima AP; Mello-Andrade F; Rezende MRM; Goveia RM; Pires WC; Silva MM; Oliveira KM; Ferreira AG; Ellena J; Deflon VM; Grisolia CK; Batista AA; Silveira-Lacerda EP
    Dalton Trans; 2019 May; 48(18):6026-6039. PubMed ID: 30724926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperthermia-mediated drug delivery induces biological effects at the tumor and molecular levels that improve cisplatin efficacy in triple negative breast cancer.
    Dunne M; Dou YN; Drake DM; Spence T; Gontijo SML; Wells PG; Allen C
    J Control Release; 2018 Jul; 282():35-45. PubMed ID: 29673642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
    Scolaro C; Bergamo A; Brescacin L; Delfino R; Cocchietto M; Laurenczy G; Geldbach TJ; Sava G; Dyson PJ
    J Med Chem; 2005 Jun; 48(12):4161-71. PubMed ID: 15943488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ruthenium metallodendrimer against triple-negative breast cancer in mice.
    Michlewska S; Wójkowska D; Watala C; Skiba E; Ortega P; de la Mata FJ; Bryszewska M; Ionov M
    Nanomedicine; 2023 Sep; 53():102703. PubMed ID: 37591367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel tetranuclear ruthenium(II) arene complexes showing potent cytotoxic and antimetastatic activity as well as low toxicity in vivo.
    Mohamed Subarkhan MK; Ren L; Xie B; Chen C; Wang Y; Wang H
    Eur J Med Chem; 2019 Oct; 179():246-256. PubMed ID: 31255925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arene-ruthenium(II) acylpyrazolonato complexes: apoptosis-promoting effects on human cancer cells.
    Pettinari R; Pettinari C; Marchetti F; Skelton BW; White AH; Bonfili L; Cuccioloni M; Mozzicafreddo M; Cecarini V; Angeletti M; Nabissi M; Eleuteri AM
    J Med Chem; 2014 Jun; 57(11):4532-42. PubMed ID: 24793593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, catalytic properties and biological activity of new water soluble ruthenium cyclopentadienyl PTA complexes [(C5R5)RuCl(PTA)2] (R = H, Me; PTA = 1,3,5-triaza-7-phosphaadamantane).
    Akbayeva DN; Gonsalvi L; Oberhauser W; Peruzzini M; Vizza F; Brüggeller P; Romerosa A; Sava G; Bergamo A
    Chem Commun (Camb); 2003 Jan; (2):264-5. PubMed ID: 12585422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.
    Du J; Kang Y; Zhao Y; Zheng W; Zhang Y; Lin Y; Wang Z; Wang Y; Luo Q; Wu K; Wang F
    Inorg Chem; 2016 May; 55(9):4595-605. PubMed ID: 27093574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental and theoretical investigations of cyclometalated ruthenium(ii) complex containing CCC-pincer and anti-inflammatory drugs as ligands: synthesis, characterization, inhibition of cyclooxygenase and in vitro cytotoxicity activities in various cancer cell lines.
    Tabrizi L; Olasunkanmi LO; Fadare OA
    Dalton Trans; 2019 Jan; 48(2):728-740. PubMed ID: 30560261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
    Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
    J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sn- and Ge- triorganometallics exert different cytotoxicity and modulation of migration in triple-negative breast cancer cell line MDA-MB-231.
    Hunakova L; Brtko J
    Toxicol Lett; 2017 Sep; 279():16-21. PubMed ID: 28709983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.